| Ref ID | 910 |
| First Author | W. Siemens |
| Journal | JOURNAL OF CLINICAL EPIDEMIOLOGY |
| Year Of Publishing | 2022 |
| URL | https://www.sciencedirect.com/science/article/pii/S0895435622002323?via%3Dihub |
| Keywords |
• COVID • Protocols • Living • Pre-specification • Non-Cochrane reviews |
| Problem(s) |
• No registered or published protocol |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | Germany |
| Aim | The aim of this study is to describe (1) registered and (2) published systematic reviews (SRs) on COVID-19 treatments, and to analyze (3) the proportion of publications among registered SRs and (4) the proportion of registrations among published SRs. |
| Level of Investigation | Analytical |
| Summary of Findings | From 239 included systematic review of COVID-19 treatments registered in PROSPERO and in the COVID-19 Living Overview of the evidence ( https://app.iloveevidence.com). A total of 71 of 239 PROSPERO protocols (29.7%) were published as full systematic reviews. In the L·OVE sample, 261 of 346 systematic reviews (75.4%) were not registered in PROSPERO before publication. |
| Number of systematic reviews included | 239 |
| Number of eligible systematic reviews assessed | 595 |
| Treatment impacted | No |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |